AGP Executive Report
Last update: 11 hours agoDEA Rescheduling Hearing: The DEA kicked off its hearing on moving cannabis to Schedule III, with officials arguing the focus is regulation and pointing to marijuana’s medical benefits and relative safety versus alcohol and opioids, while reform advocates complain they’re shut out of testimony. Virginia Retail Rollout: Virginia approved a path for recreational marijuana sales, clearing the way for up to 350 licensed shops starting July 1, 2027, alongside higher possession limits and a separate medical program. Hawaii Enforcement Pressure: Hawaii hemp and CBD retailers face enforcement starting Wednesday, with state health officials warning many products on shelves may be illegal under new rules and some owners rushing to court. Hemp Sellers in Court: Hemp retailers head to court to fight new rules as regulators tighten what’s allowed. Youth Substance Use Alarm: Guyana’s health minister says screening found high rates of alcohol, vaping, and some cannabis use among secondary students, calling for stronger prevention. CBD/Health Research: A cord-blood stem cell trial is recruiting to test feasibility and safety for protecting preterm babies’ brains after injury. Business Moves: Tilray plans to acquire HelloMD to expand direct-to-patient medical cannabis access in Canada. Safety & Compliance: A police case in Queensland charged a man after a vehicle search allegedly found cannabis, MDMA, cash, and a knife.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
